Completed 4th Annual 2015 MI Foundation Health & Vision Screening

 Mezu International Foundation Inc.
(a 501 (c) public charity organization)

On April 1st to April 3rd, 2015, The Mezu International Foundation held its 4th Annual Free Health and Vision Screening, in cooperation with Aqua Vision Care, LLC, VSP Mobile Clinic, Allergan and Alcon Inc.

The Mezu International Foundation Inc, a non-profit organization, provided FREE Health & Vision Screenings and gave complete eyeglasses to many people from underprivileged families. Glasses were provided free to children, men and women with refractive errors.4rd Annual MI Foundation Health 2015

At the Free Screening, over 200 participants were given Free Eye Examinations by licensed Doctors of Optometry from Aqua Vision Care, LLC as well as Other Volunteer optometrists and Student Interns from Omni Eye Specialists. Patients received Free Frames and Sunglasses, courtesy of VSP Mobile Van, a VSP Charity organization and Europa Eyewear and free ophthalmic lenses with varied prescriptions from Essilor Vision Foundation.

Donations of various Ocular Medications, contact lens solutions, and Eye Vitamins were also received from Alcon Inc and Allergan.

Out of the Over 200 patients seen, 38% of the population were male, while 62% were female, 57% had myopia, 47.1% had hyperopia, 94.2% had astigmatism (simple, myopic, hyperopic).

The prevalence of cataracts was 37.2% while Glaucoma was seen in 2.5% of the population. 40.5% of the patients had ocular allergy symptoms, while 28.1% were first time wearers.

The prevalence of hypertension in the population screened was 33.3%, while 12.5% had diabetes, both obtained by Case History.

Chart by Visualizer
Chart by Visualizer

Research shows that around the world, 284 million people suffer from poor vision because they don’t have access to or can’t afford glasses. Here in the United States, there were more than 142 million people in the United States age 40 and older with vision problems and about 1 in every 10 kids with vision issues.